• Basaria S., Lieb J. 2nd, Tang AM, DeWeese T., Carducci M., Eisenberger M., Dobs AS. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf). 2002;56: 779786.
  • Bizzarro A., Valentini G., DiMartino G., DaPonte A., De Bellis A., Iacono G.. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab. 1987; 64: 32–36.
  • Khosla S., Atkinson EJ, Dunstan CR, O'Fallon WM. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab. 2002;87: 15501554.
  • Landis SH, Murray T., Bolden S., Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49: 831.
  • Maggio M., Basaria S., Ble A., Lauretani F., Bandinelli S., Ceda GP, Valenti G., Ling SM, Ferrucci L.. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab. 2006;91: 345347.
  • Malkin CJ, Pugh PJ, Jones RD, Kapoor D., Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89: 33133318.
  • Messing EM, Manola J., Sarosdy M., Wilding G., Crawford ED, Trump D.. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341: 17811788.
  • Pfitzenmaier J., Vessella R., Higano CS, Noteboom JL, Wallace D. Jr, Corey E.. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer. 2003;97: 12111216.
  • Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, Kantoff PW. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002;87: 599603.
  • Spinedi E., Suescun MO, Hadid R., Daneva T., Gaillard RC. Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology. 1992;131: 24302436.
  • Wise GJ, Marella VK, Talluri G., Shirazian D.. Cytokine variations in patients with hormone treated prostate cancer. J Urol. 2000;164: 722725.